CustomVue™ Clinical Study Results

The U.S. Food and Drug Administration (FDA) has approved the VISX CustomVue™ procedure as a safe and effective method for correcting nearsightedness and astigmatism. A significant visual acuity result of the FDA clinical study was that six months after the VISX CustomVue™ procedure:

• 100% of participants could see well enough to legally drive a car (20/40 or better) without glasses or contacts
• 94% of participants achieved uncorrected visual acuity of 20/20 or better 74% of participants were 20/16 or better
• Four times as many participants were very satisfied with their night vision after CustomVue™, compared to their night vision with their glasses or contact lenses.

Overall, many participants were more satisfied with their quality of vision after the VISX CustomVue procedure than before the procedure with use of glasses or contacts. Quality of vision refers to not only what you see, but also how well you see under a variety of conditions, such as driving at night. Uncorrected visual acuity is the measurement of how well you see without the aid of glasses or contact lenses.